Edition:
United Kingdom

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

7.29USD
18 Oct 2018
Change (% chg)

$-0.14 (-1.88%)
Prev Close
$7.43
Open
$7.40
Day's High
$7.41
Day's Low
$7.09
Volume
52,786
Avg. Vol
130,071
52-wk High
$15.12
52-wk Low
$5.59

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.889
Mar '18 0.00 -0.914
FY 2017 Dec '17 0.00 -0.605
Sep '17 0.00 -0.635
Jun '17 0.00 -0.638
Mar '17 0.00 -0.602
FY 2016 Dec '16 0.00 -0.712
Sep '16 0.00 -0.671
Jun '16 0.00 -0.703
Mar '16 0.01 -0.485
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 3 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 0.61
Year Ending Dec-19 4 0.00 0.00 0.00 0.05
Earnings (per share)
Quarter Ending Dec-18 4 -0.69 -0.67 -0.72 -0.57
Quarter Ending Mar-19 2 -0.73 -0.70 -0.76 --
Year Ending Dec-18 4 -3.12 -3.06 -3.18 -2.39
Year Ending Dec-19 4 -2.63 -2.60 -2.68 -2.14
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.83 33.69
P/E High - Last 5 Yrs. -- 288.76 45.21
P/E Low - Last 5 Yrs. -- 90.17 23.79
Beta -- 0.93 0.88
Price to Sales (TTM) -- 123.60 5.82
Price to Book (MRQ) 1.80 15.31 4.89
Price to Tangible Book (MRQ) 1.80 14.52 6.52
Price to Cash Flow (TTM) -- 70.45 22.95
% Owned Institutions 37.32 14.08 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.55 5.39
Payout Ratio(TTM) -- 16.83 43.91

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 413.48 8.02
Sales (TTM) vs TTM 1 Yr. Ago -100.00 103.91 5.75
Sales - 5 Yr. Growth Rate -- 30.81 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 9.29 24.33 23.65
EPS (TTM) vs TTM 1 Yr. Ago -6.41 -- --
EPS - 5 Yr. Growth Rate -- 37.81 10.95
Capital Spending - 5 Yr. Growth Rate -- 38.61 14.90

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) 9.72 5.34 3.05
LT Debt to Equity (MRQ) 0.00 34.95 12.73
Total Debt to Equity (MRQ) 0.00 36.76 17.15
Interest Coverage (TTM) -2,876.89 -97.17 37.58

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.15 54.90
Gross Margin - 5 Yr. Avg. -- 49.21 52.43
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -575.88 11.08
Operating Margin (TTM) -- -770.08 4.31
Operating Margin - 5 Yr. Avg. -- -596.20 6.43
Pre-Tax Margin (TTM) -- -732.14 5.36
Pre-Tax Margin - 5 Yr. Avg. -- -601.79 6.86
Net Profit Margin (TTM) -- -733.08 1.64
Net Profit Margin - 5 Yr. Avg. -- -604.76 3.11
Effective Tax Rate (TTM) -- 23.64 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.79 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,788,701 810,573,943
Net Income/Employee (TTM) -2,371,687 1,717,126 95,338,757
Receivable Turnover (TTM) -- 19.81 5.77
Inventory Turnover (TTM) -- 2.38 3.62
Asset Turnover (TTM) 0.00 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -49.54 -1.09 10.92
Return on Assets - 5 Yr. Avg. -- 3.20 12.03
Return on Investment (TTM) -55.80 0.58 14.30
Return on Investment - 5 Yr. Avg. -- 2.28 15.63
Return on Equity (TTM) -55.80 1.62 16.03
Return on Equity - 5 Yr. Avg. -- 3.07 16.90
  1 Year 3 Year 5 Year
Sales % -97.40 -80.27 --
EPS (TTM) % 8.42 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Zynerba Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 52.61 47.34 99 59
13 Week -45.33 -47.99 9 63
26 Week -56.27 -59.59 17 76
52 Week -26.93 -38.07 63 47
YTD -38.04 -45.58 36 57
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 16.20%
# of Holders: 73
Total Shares Held: 2,855,233
3 Mo. Net Change: -15,511
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 7
# Reduced Positions: 3
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.